Replies to post #39086 on Biotech Values

[DewDiligence]

No VRTX CC—this is just one of many interim data reports that will be coming vis-à-vis the PROVE-n trials.

I don’t know the historical dropout rate on SoC off the top of my head, but it would be apples vs oranges since we’re talking about comparisons at 48 weeks vs 12 weeks.

ITMN ought to do well today.